Cargando…
Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells
Prostate cancer is the most common malignancy in men and the second cause of cancer-related deaths in western countries. Despite the progress in the treatment of localized prostate cancer, there is still lack of effective therapies for the advanced forms of the disease. Most patients with advanced p...
Autores principales: | Civenni, Gianluca, Albino, Domenico, Shinde, Dheeraj, Vázquez, Ramiro, Merulla, Jessica, Kokanovic, Aleksandra, Mapelli, Sarah N., Carbone, Giuseppina M., Catapano, Carlo V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521702/ https://www.ncbi.nlm.nih.gov/pubmed/31143708 http://dx.doi.org/10.3389/fonc.2019.00385 |
Ejemplares similares
-
EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer
por: Zoma, Marita, et al.
Publicado: (2021) -
The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment
por: Albino, Domenico, et al.
Publicado: (2016) -
Mitochondrial fission and stemness in prostate cancer
por: Civenni, Gianluca, et al.
Publicado: (2019) -
Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer
por: Albino, Domenico, et al.
Publicado: (2021) -
A Novel Prostate Cell Type-Specific Gene Signature to Interrogate Prostate Tumor Differentiation Status and Monitor Therapeutic Response (Running Title: Phenotypic Classification of Prostate Tumors)
por: Mapelli, Sarah N., et al.
Publicado: (2020)